Breaking Biotech

005 - AnaptysBio Phase 2a data breakdown and Biotech portfolio reveal!


Listen Later

-AnaptysBio shows positive phase 2a data from their peanut allergy study with ANB020 https://ir.anaptysbio.com/news-releases/news-release-details/anaptysbio-announces-positive-top-line-proof-concept-data-anb020 -Check out the PRACTALL guidelines for Oral Food Challenges https://www.siaip.it/upload/StandardizingDBPCFCPRACTALL_2012.pdf -I'm not taking a position because with such a small sample size, and convoluted inclusion criteria, I need to see more data
...more
View all episodesView all episodes
Download on the App Store

Breaking BiotechBy Matthew Lepoire

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

24 ratings